Turnaround time

ChromaCode To Show New Data In Oncology and Blood Based Monitoring at the Association for Molecular Pathology 2023 Annual Meeting and Expo

Retrieved on: 
Tuesday, October 31, 2023

CARLSBAD, Calif., Oct. 31, 2023 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable solutions for laboratories, will present new data during a Corporate workshop and present two accepted scientific abstracts at the Association for Molecular Pathology (AMP) 2023 annual meeting, being held at the Salt Palace Convention Center in Salt Lake City, Utah, from November 14-18, 2023.

Key Points: 
  • "The ChromaCode team is proud to participate in this year's preeminent conference for molecular diagnostics, AMP 2023.
  • At the Corporate Workshop, we will be revealing new data showcasing the potential of HDPCR enabled multiplexing and ChromaCode software in transplant and minimal residual disease.
  • We look forward to engaging with fellow attendees at these presentations and at our Booth (1700)" stated Mark McDonough, Chief Executive Officer at ChromaCode.
  • Attendees can expect insights into the latest software tools, data analysis techniques, and their potential to enhance precision and accuracy in molecular testing.

NielsenIQ Brandbank Announces Changes to Content Licensing Subscription Model Enabling Brands to Share Images and Content Anywhere

Retrieved on: 
Tuesday, January 31, 2023

Today, NielsenIQ Brandbank, the leading provider of digital product content solutions, announced it has launched new content creation services that enable brands unlimited content usage.

Key Points: 
  • Today, NielsenIQ Brandbank, the leading provider of digital product content solutions, announced it has launched new content creation services that enable brands unlimited content usage.
  • The new content creation services offer brands a simple way to consolidate service providers by giving brands unlimited rights to share all NielsenIQ Brandbank created images with any third party and agency with no cost.
  • “We’re democratizing product content licensing and enabling brands to share their high-quality images and content anywhere.”
    NielsenIQ Brandbank provides retailers and brands with robust digital content to support shoppers’ omnichannel experience and is uniquely positioned to redefine what best in class digital product content is and deliver it at scale.
  • The new content creation services offer the following benefits:
    Unlimited Content Usage: Unlimited rights to share ALL NielsenIQ Brandbank created content with any third party / agency with no cost.

U.S. Acute Hospital Care Market Report 2022-2030: Analysis by Medical Condition (Emergency Care, Trauma Care), & Facility Type, by Service (Intensive Care Unit, Neonatal Intensive Care Unit) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 12, 2022

Acute Hospital Care Market Size, Share & Trends Analysis Report by Medical Condition (Emergency Care, Trauma Care), by Facility Type, by Service (Intensive Care Unit, Neonatal Intensive Care Unit), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Acute Hospital Care Market Size, Share & Trends Analysis Report by Medical Condition (Emergency Care, Trauma Care), by Facility Type, by Service (Intensive Care Unit, Neonatal Intensive Care Unit), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Increasing incidence of trauma, demand for acute hospitals, and unmet medical needs are expected to boost growth.
  • As per the CMS Hospital Compare List, the U.S. has roughly 4,749 acute care hospitals.
  • Acute hospital care aims to help patients attain stable and healthy medical conditions as well as discharge them as early as possible.

Farmer Brothers Announces Opening of West Coast Distribution Center

Retrieved on: 
Tuesday, February 2, 2021

With 40% of Farmer Brothers customers located on the West Coast, the Company expects this new distribution center to enable the Company to fulfill product orders more quickly, improve delivery times and provide better customer service, leading to meaningful transportation and distribution efficiencies.

Key Points: 
  • With 40% of Farmer Brothers customers located on the West Coast, the Company expects this new distribution center to enable the Company to fulfill product orders more quickly, improve delivery times and provide better customer service, leading to meaningful transportation and distribution efficiencies.
  • The facility is also designed to mitigate future capital expenditure requirements for customer equipment with its new coffee brewing equipment (CBE) refurbishing center.
  • Deverl Maserang, Chief Executive Officer, commented, Im excited to be returning Farmer Brothers to its West Coast roots with this outstanding new facility.
  • The new West Coast facility will provide better CBE servicing and faster turnaround times for customers.

Unique Multicenter Study Shows Implementation of COPAN's WASP® and WASPLab® in Various Microbiology Lab Settings is a Cost-Savings, Efficiency-Increasing Move

Retrieved on: 
Saturday, December 5, 2020

While many studies have examined the advantages of automation, most focus on the positive effect it has on turnaround times for culture results.

Key Points: 
  • While many studies have examined the advantages of automation, most focus on the positive effect it has on turnaround times for culture results.
  • WASPLab is a modular, scalable and customizable specimen processing and culture work-up system for Clinical Microbiology.
  • Before the implementation of full laboratory automation, the average turnaround time for urine culture at Willis-Knighton Health System clocked in at 30.8 hours.
  • After converting to a fully automated facility, the Microbiology lab cut its turnaround time to 23.0 hours, resulting in a 7.8 hours faster process.

Property Damage Appraisers Continues Focus on Innovation by Launching New Services in 2020

Retrieved on: 
Tuesday, July 21, 2020

FORT WORTH, Texas, July 21, 2020 /PRNewswire/ -- Property Damage Appraisers Inc. (PDA) , the nation's leading independent damage estimating firm, provides clients with the fastest damage estimate turnaround times in the industry.

Key Points: 
  • FORT WORTH, Texas, July 21, 2020 /PRNewswire/ -- Property Damage Appraisers Inc. (PDA) , the nation's leading independent damage estimating firm, provides clients with the fastest damage estimate turnaround times in the industry.
  • So far in 2020, the brand has launched Specialty/Heavy Equipment Same-Day Service, the Public Displays of Appreciation campaign, and PDA Virtual.
  • PDA continues its focus on innovation, customer service and efficiency, wrapping up the first part of 2020 on a high note.
  • In April 2020, the firm announced that it would be expanding the Same-Day Service offering with Specialty/Heavy Equipment Same-Day Service.

Isola Opens Expanded R&D and Analytical Laboratory at New Global Headquarters and Manufacturing Facility

Retrieved on: 
Thursday, June 18, 2020

The Arizona operations also include a 118,000-square-foot quick-turnaround manufacturing facility to accommodate the industry's agile demands.

Key Points: 
  • The Arizona operations also include a 118,000-square-foot quick-turnaround manufacturing facility to accommodate the industry's agile demands.
  • In the R&D and analytical lab, Isola incorporated a refined and optimized workflow with dedicated space for each testing process.
  • These dedicated spaces provide a more optimal working environment for Isola technicians, chemists, and researchers, benefiting customers through enhanced efficiency.
  • "The expanded R&D and analytical services laboratory furthers our ability to both improve analytical capability and maintain quick turnaround times."

Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology’s Standard of Care with Genomics Technology Collaboration

Retrieved on: 
Wednesday, June 3, 2020

The Ion Torrent Genexus System improves turnaround time and minimizes human error for genome profiling, resulting in better delivery of services and further differentiating the Q2 Solutions service offering.

Key Points: 
  • The Ion Torrent Genexus System improves turnaround time and minimizes human error for genome profiling, resulting in better delivery of services and further differentiating the Q2 Solutions service offering.
  • Q2 Solutions is committed to implementing transformational technology that has the potential to revolutionize how complex diseases are managed.
  • Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
  • Q2 Solutions works with clients, using a wide array of technology platforms, to ensure maximum efficiency and quality delivery for every study.

IDEXX Launches Rapid Digital Cytology Service to Further Accelerate Delivery of Veterinary Healthcare

Retrieved on: 
Friday, January 17, 2020

IDEXX Digital Cytology will be available to IDEXX customers in North America by mid-February.

Key Points: 
  • IDEXX Digital Cytology will be available to IDEXX customers in North America by mid-February.
  • With the accelerated turnaround times, veterinary teams will be more equipped to speed up their healthcare delivery in what can often be high-anxiety situations for pet owners.
  • Veterinarians using IDEXX Reference Laboratories for digital cytology will also use existing workflows for specimen submission.
  • "IDEXX Digital Cytology is our most recent innovation designed to bring reference laboratory-quality diagnostics to the point of care, speed up veterinary healthcare delivery, and advance the standard of care.

QIAGEN and NeuMoDx expand assay menu for their next generation of fully integrated PCR systems for clinical laboratories in Europe and also announce availability of NeuMoDx 96 version

Retrieved on: 
Thursday, April 11, 2019

NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases.

Key Points: 
  • NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases.
  • The NeuMoDx systems are disruptive next-generation solutions for clinical laboratories that process molecular diagnostic tests, including full automation, scalability, and cost efficiency.
  • Rapid insights for clinicians: The NeuMoDx 288 and 96 systems offer turnaround times as low as 40 minutes, compared to more than three hours for other systems.
  • NeuMoDx Molecular, based in Ann Arbor, Michigan, designs and develops revolutionary molecular diagnostic solutions for hospital and clinical reference laboratories.